Development of an Intravenous Formulation of SU010382 (Prodrug of SU5416, an Anti-Angiogenesis Agent)

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

You are going to email the following Development of an Intravenous Formulation of SU010382 (Prodrug of SU5416, an Anti-Angiogenesis Agent)

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.